John Trizzino

John Trizzino is executive vice president, chief business officer, and chief financial officer at Novavax, responsible for all pre-commercial and commercial launch strategy and execution, financial reporting, corporate funding, and investor/public relations. He had previously served as senior vice president of commercial operations. Trizzino has an extensive background in the vaccine market, with roles overseeing commercialization, vaccine policy, strategic development, business development, financing, investor relations, and public relations. Earlier, he was CEO of Immunovaccine, successfully leading the company into clinical development of its lead candidate while securing the required funding commitments in the equity market as well as non-dilutive sources. Prior to Novavax and Immunovaccine, Trizzino held leadership positions at MedImmune, ID Biomedical, and Henry Schein, all focused on infectious disease vaccine markets.